{
 "as_of": "2026-11-06",
 "cmr": "pl-cm-kg/XWAR/PLMBION00016",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# MABION (GPW Main Market: PLMBION00016) — research page\n\nAs of 2026-11-06 · pl-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is MABION, listed on the GPW Main Market under ticker PLMBION00016, with ISIN PLMBION00016 and LEI 259400KG5JVQPPZL6X53. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 46 filings in the twelve months to 2026-11-06, on 41 filing days. Of these, 42 are ESPI Current, 2 are ESPI Quarterly, 1 is ESPI half years and 1 is EBI Current. The median gap between filing days is 8.5 days. The latest filing is an ESPI Current dated 2026-11-04, 2 days before the record date. The GPW Main Market has 436 issuers with a median cadence gap of 8.0 days, a median of 31.0 filings and a median latency of 10 days. The sector peer figures are not on the record for this market.\n\n## Auditor\n\nThe auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed, not halted.\n\n## Orderability\n\nThe outcome cannot be determined, because the chapter's orderability section carries no client categories. Rule version acm-68000/pl/mifid-ii-product-governance/r1 applies, with the chapter as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 7 research houses: mBank, BM PKO BP, DM Trigon, Noble Securities, Ipopema Securities, BM Santander and Noble Securities S.A.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No years are sealed for this issuer, and the live record began on a date not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.pl-cm-kg.ai/events/XWAR/PLMBION00016 (the disclosure lines)\n- https://www.gpw.pl/zawieszenia-i-wykluczenia (the halt flag)\n- https://pl.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.mabion.eu/analysts/ (coverage)\n- https://mcp.pl-cm-kg.ai/record/XWAR/PLMBION00016 (the record)\n",
 "market": "PL",
 "node": "pl-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the PL vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "PL",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "PL",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "PL",
    "state": "not_on_record"
   },
   "changes": {
    "market": "PL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "pl-cm-kg/XWAR/PLMBION00016",
  "coverage": {
   "count": 7,
   "houses": [
    {
     "analyst": "Beata Szparaga-Waśniewska",
     "house": "mBank",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.mabion.eu/analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Dawid Górzyński",
     "house": "BM PKO BP",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.mabion.eu/analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Katarzyna Kosiorek",
     "house": "DM Trigon",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.mabion.eu/analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Krzysztof Radojewski",
     "house": "Noble Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.mabion.eu/analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Łukasz Kosiarski",
     "house": "Ipopema Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.mabion.eu/analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Tomasz Krukowski",
     "house": "BM Santander",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.mabion.eu/analysts/",
     "state": "sourced"
    },
    {
     "house": "Noble Securities S.A.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.mabion.eu/analysts/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.mabion.eu/analysts/",
     "result": "read: 7 of 13 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 436,
     "median_cadence_gap_days": 8,
     "median_filings": 31,
     "median_latency_days": 10,
     "name": "GPW Main Market"
    },
    "sector": {
     "market": "PL",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "EBI Current": 1,
    "ESPI Current": 42,
    "ESPI Quarterly": 2,
    "ESPI half years": 1
   },
   "cadence_median_gap_days": 8.5,
   "filing_days": 41,
   "filings": 46,
   "latency_days": 2,
   "latest": [
    {
     "category": "ESPI Current",
     "date": "2026-11-04",
     "source": "https://www.gpw.pl/espi-ebi-report?geru_id=500037&title=Ameryka%C5%84ska+Agencja+ds.+%C5%BBywno%C5%9Bci+i+Lek%C3%B3w+FDA+wspiera+rejestracj%C4%99+MabionCD20+jako+innowacyjnego+leku+biologicznego",
     "title": "Amerykańska Agencja ds. Żywności i Leków (FDA) wspiera rejestrację MabionCD20 jako innowacyjnego leku biologicznego",
     "type": "ESPI Current"
    },
    {
     "category": "ESPI Current",
     "date": "2026-10-20",
     "source": "https://www.gpw.pl/espi-ebi-report?geru_id=499086&title=Wa%C5%BCna+aktualizacja+dotycz%C4%85ca+MabionCD20.+Oddifact+SAS+og%C5%82asza%2C+%C5%BCe+w+wyniku+konsultacji+z+ameryka%C5%84sk%C4%85+Agencj%C4%85+ds.+%C5%BBywno%C5%9Bci+i+Lek%C3%B3w+FDA+MabionCD20+mo%C5%BCe+by%C4%87+stosowany+jako+terapia+pierwszego+rzutu%2C+a+czas+trwania+badania+mo%C5%BCe+zosta%C4%87+znacznie+skr%C3%B3cony+do+za",
     "title": "Ważna aktualizacja dotycząca MabionCD20. Oddifact SAS ogłasza, że w wyniku konsultacji z amerykańską Agencją ds. Żywności i Leków (FDA) MabionCD20 może być stosowany jako terapia pierwszego rzutu, a czas trwania badania może zostać znacznie skrócony do za",
     "type": "ESPI Current"
    },
    {
     "category": "ESPI Current",
     "date": "2026-10-06",
     "source": "https://www.gpw.pl/espi-ebi-report?geru_id=498381&title=Spotkanie+Pre-IND+Typu+B+z+ameryka%C5%84sk%C4%85+Agencj%C4%85+ds.+%C5%BBywno%C5%9Bci+i+Lek%C3%B3w+FDA+-+kolejny+kamie%C5%84+milowy+na+drodze+do+wprowadzenia+MabionCD20+jako+leku+sierocego+stosowanego+w+leczeniu+immunologicznej+trombocytopenii+ITP",
     "title": "Spotkanie Pre-IND Typu B z amerykańską Agencją ds. Żywności i Leków (FDA) - kolejny kamień milowy na drodze do wprowadzenia MabionCD20 jako leku sierocego stosowanego w leczeniu immunologicznej trombocytopenii (ITP)",
     "type": "ESPI Current"
    },
    {
     "category": "ESPI Current",
     "date": "2026-10-01",
     "source": "https://www.gpw.pl/espi-ebi-report?geru_id=498083&title=Rozszerzenie+wsp%C3%B3%C5%82pracy+z+WPD+Pharmaceuticals+S.A.+-+list+intencyjny+dotycz%C4%85cy+wsp%C3%B3lnej+realizacji+programu+rozwoju+biologicznych+produkt%C3%B3w+leczniczych+opartych+na+terapii+celowanej+w+obszarze+onkologii",
     "title": "Rozszerzenie współpracy z WPD Pharmaceuticals S.A. - list intencyjny dotyczący wspólnej realizacji programu rozwoju biologicznych produktów leczniczych opartych na terapii celowanej w obszarze onkologii",
     "type": "ESPI Current"
    },
    {
     "category": "ESPI Current",
     "date": "2026-09-15",
     "source": "https://www.gpw.pl/espi-ebi-report?geru_id=496995&title=Mabion+S.A.+zostanie+poddany+inspekcji+ameryka%C5%84skiej+Agencji+ds.+%C5%BBywno%C5%9Bci+i+Lek%C3%B3w+FDA",
     "title": "Mabion S.A. zostanie poddany inspekcji amerykańskiej Agencji ds. Żywności i Leków (FDA)",
     "type": "ESPI Current"
    }
   ],
   "latest_filing_date": "2026-11-04",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.pl-cm-kg.ai/events/XWAR/PLMBION00016",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/",
    "state": "sourced",
    "value": "GPW Main Market"
   },
   "isin": {
    "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/",
    "state": "sourced",
    "value": "PLMBION00016"
   },
   "jurisdiction": {
    "market": "PL",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN PLMBION00016)",
    "state": "sourced",
    "value": "259400KG5JVQPPZL6X53"
   },
   "name": {
    "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/",
    "state": "sourced",
    "value": "MABION"
   },
   "sector": {
    "market": "PL",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "PL",
    "state": "not_on_record"
   },
   "segment": {
    "market": "PL",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/",
    "state": "sourced",
    "value": "PLMBION00016"
   },
   "website": {
    "market": "PL",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "PL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "PL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "PL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "PL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "PL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "PL",
  "node": "pl-cm-kg",
  "numbers_hash": "sha256:98691ed6d14542a4cc54dc2704689e67c836d3cd9bb3e3be67ab6d973bf65bd8",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://pl.eu-cm-kg.ai/book/aio.json",
    "door": "https://pl.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/pl/mifid-ii-product-governance/r1",
   "section": "pl.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.pl-cm-kg.ai/record/XWAR/PLMBION00016",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://www.gpw.pl/zawieszenia-i-wykluczenia",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:98691ed6d14542a4cc54dc2704689e67c836d3cd9bb3e3be67ab6d973bf65bd8",
 "path": "/pl/XWAR/PLMBION00016",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is MABION, listed on the GPW Main Market under ticker PLMBION00016, with ISIN PLMBION00016 and LEI 259400KG5JVQPPZL6X53. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 46 filings in the twelve months to 2026-11-06, on 41 filing days. Of these, 42 are ESPI Current, 2 are ESPI Quarterly, 1 is ESPI half years and 1 is EBI Current. The median gap between filing days is 8.5 days. The latest filing is an ESPI Current dated 2026-11-04, 2 days before the record date. The GPW Main Market has 436 issuers with a median cadence gap of 8.0 days, a median of 31.0 filings and a median latency of 10 days. The sector peer figures are not on the record for this market.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome cannot be determined, because the chapter's orderability section carries no client categories. Rule version acm-68000/pl/mifid-ii-product-governance/r1 applies, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 7 research houses: mBank, BM PKO BP, DM Trigon, Noble Securities, Ipopema Securities, BM Santander and Noble Securities S.A.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No years are sealed for this issuer, and the live record began on a date not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.pl-cm-kg.ai/events/XWAR/PLMBION00016"
  },
  {
   "for": "the halt flag",
   "source": "https://www.gpw.pl/zawieszenia-i-wykluczenia"
  },
  {
   "for": "the orderability chapter",
   "source": "https://pl.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.mabion.eu/analysts/"
  },
  {
   "for": "the record",
   "source": "https://mcp.pl-cm-kg.ai/record/XWAR/PLMBION00016"
  }
 ],
 "title": "MABION (PLMBION00016) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}